Advertisement
Screener

Relay Therapeutics, Inc. (RLAY) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Relay Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Relay Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $235.46M went out.
  • Fiscal year ended 2025-12-31: from investing, $192.80M came in.
  • Fiscal year ended 2025-12-31: from financing, $1.60M came in.
  • Fiscal year ended 2025-12-31: change in cash, $41.05M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$235.46M$192.80M$1.60M*-$41.05M
2024-12-31-$249.11M-$41.08M$270.15M*-$20.04M
2023-12-31-$300.32M$257.63M$34.75M*-$7.93M
2022-12-31-$229.49M-$188.75M$1.69M$288.22M*-$128.32M
2021-12-31-$74.41M-$479.51M$4.74M$383.35M*-$165.83M
2020-12-31-$102.49M$81.67M$1.22M$425.29M*$405.69M
2019-12-31-$66.13M-$319.02M$613.00K$4.99M*-$379.55M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$54.11M*-$353.03M*$323.74M*
2026-03-31-$51.11M$32.90M$138.78M*$120.57M
2025-12-31-$44.87M*$35.46M*$934.00K*
2025-09-30-$62.12M*$39.73M*
2025-06-30-$55.26M*$75.15M*
2025-03-31-$73.21M$42.47M-$30.75M
2024-12-31-$57.87M*$29.00M*$800.00K*
2024-09-30-$75.08M*-$126.16M*$218.89M*
2024-06-30-$65.83M*$45.55M*$1.54M*
2024-03-31-$50.32M$10.53M$48.92M*$9.13M
2023-12-31-$89.19M*$59.68M*$21.92M*
2023-09-30-$75.40M*$71.36M*$9.46M*
2023-06-30-$68.60M*$51.28M*$2.08M*
2023-03-31-$67.13M$75.31M$1.30M*$9.48M
2022-12-31-$57.08M*-$146.94M*$549.00K*$617.00K*
2022-09-30-$66.14M*$27.19M*$1.12M*$284.74M*
2022-06-30-$57.09M*$43.39M*$859.00K*$1.14M*
2022-03-31-$49.17M-$112.38M$883.00K-$160.67M
2021-12-31-$39.71M*-$292.75M*$661.00K*$383.35M*
2021-09-30-$53.20M*$20.79M*$902.00K*
2021-06-30-$28.14M*$26.07M*$1.12M*
2021-03-31$46.64M-$233.62M$2.06M-$184.93M
2020-12-31-$35.27M*-$76.42M*$56.00K*
2020-09-30-$24.04M*$20.07M*$442.00K*$425.75M*
2020-06-30-$20.84M*$87.65M*$367.00K*
2020-03-31-$22.33M$50.37M$351.00K$28.39M
2019-12-31-$22.76M*$35.90M*$441.00K*
2019-09-30-$17.50M*$7.08M*$120.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)United States$4.897B-6.51
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12